MedPath

Randomized prospective study for the evaluation of the clinical long-term behavior of all-ceramic partial crowns and onlays made of VITA Suprinity®

Not Applicable
Conditions
partial dental hart tissue losing
Registration Number
DRKS00005611
Lead Sponsor
VITA Zahnfabrik H. Rauter GmbH & Co. KG
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Men or women age 18+
•written consent for the participation/capacity to consent
•Posterior single crowns (premolars, molars) with natural antagonistic teeth
•vital and symptom-free abutment teeth with unobtrusive initial x-ray findings*
•periodontally rehabilitated (sufficient) partially edentulous arch or no periodontal treatment required

Exclusion Criteria

missing antagonistic teeth
•antagonists on implants
•endodontic treatment
•bruxism
•patients younger than 18 years
•abutment teeth with pain symptoms
•implants as abutments
•dental treatment and/or examination cannot be performed due to poor general state of health
•existing systemic disease: diabetes mellitus, kidney insufficiency
•immunosuppressed patients: organ transplants, autoimmune disorders (rheumatic arthritis, chronic gastro-intestinal disease)
•infektious patients (hepatitis A, B, C, TBC, HIV; on inquiry)
•addicts (alcohol addiction)
•patients with seizure or nervous disorders
•existing pregnancy (on inquiry)
•allergies to ingredients of the cements (A as well as B)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Survival rate: Long-term success defined as survival of all-ceramic partial crowns/onlayss made of VITA Suprinity® ceramics after 1,2 3, 5 years, based on the criteria of Pjetursson et al. (2007).
Secondary Outcome Measures
NameTimeMethod
Success rate: Acquisition of technical and biological complications (success) after 1,2 3, 5 years, based on the criteria of Pjetursson et al. (2007).
© Copyright 2025. All Rights Reserved by MedPath